Researchers at Phylonix Pharmaceuticals have tested a number of compounds that showed anti angiogenic effects in mammals,
including SU5416 and flavopiridol. They found that a drug’s effect
on vessel inhibition in zebra fish correlated well with the effects seen
in mammals, indicating that the zebra fish is a predictive model for
testing angiogenesis inhibitors. Because angiogenesis is
involved in other diseases, such as diabetic retinopathy and macular degeneration, the angiogenesis assays are also useful for discovering therapies for these diseases